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Abstract. 
 
The cis-Golgi matrix protein GM130 is phos-
phorylated in mitosis on serine 25. Phosphorylation in-
hibits binding to p115, a vesicle-tethering protein, and 
has been implicated as an important step in the mitotic 
Golgi fragmentation process. We have generated an an-
tibody that speciﬁcally recognizes GM130 phosphory-
lated on serine 25, and used this antibody to study the 
temporal regulation of phosphorylation in vivo. GM130 
is phosphorylated in prophase as the Golgi complex 
starts to break down, and remains phosphorylated dur-
ing further breakdown and partitioning of the Golgi 
fragments in metaphase and anaphase. In telophase, 
GM130 is dephosphorylated as the Golgi fragments 
start to reassemble. The timing of phosphorylation and 
dephosphorylation correlates with the dissociation and 
reassociation of p115 with Golgi membranes. GM130 
phosphorylation and p115 dissociation appear speciﬁc 
to mitosis, since they are not induced by several drugs 
that trigger nonmitotic Golgi fragmentation. The phos-
phatase responsible for dephosphorylation of mitotic 
GM130 was identiﬁed as PP2A. The active species was 
identiﬁed as heterotrimeric phosphatase containing the 
 
B
 
a
 
 regulatory subunit, suggesting a role for this isoform 
in the reassembly of mitotic Golgi membranes at the 
end of mitosis.
Key words: Golgi • mitosis • GM130 • phosphoryla-
tion • protein phosphatase 2A
 
Introduction
 
The Golgi complex is characterized by its unique appear-
ance, resulting from the close apposition of flattened cis-
ternae arranged in parallel to form stacks. In mammalian
cells, the stacks are connected laterally by tubular connec-
tions to form a single compact reticulum often localized
adjacent to the nucleus (Rambourg and Clermont, 1997).
During cell division, the Golgi complex undergoes a dra-
matic morphological transformation (Robbins and Gona-
tas, 1964; Cabrera-Poch et al., 1998). Early in mitosis,
during prophase, the Golgi ribbon is broken down to dis-
crete stacks (Colman et al., 1985), which themselves un-
dergo more extensive fragmentation as cells progress into
metaphase, yielding clusters of small vesicles and tubules
in addition to a variable amount of free vesicles in the cy-
toplasm (Lucocq and Warren, 1987; Lucocq et al., 1987,
1989; Misteli and Warren, 1995a). The mitotic Golgi clus-
ters are partitioned between the two nascent daughter
cells by a mechanism that appears to utilize the micro-
tubules of the mitotic spindle (Shima et al., 1997, 1998).
During telophase, the vesicles and tubules of the mitotic
clusters fuse to generate stacked cisternae, which then co-
alesce and connect to reform the Golgi ribbon (Lucocq et
al., 1989; Souter et al., 1993).
Assays have been established to mimic the events of mi-
totic disassembly and reassembly in vitro (Misteli and
Warren, 1994; Rabouille et al., 1995b). Incubation of puri-
fied rat liver Golgi stacks with mitotic cytosol results in the
conversion of stacked cisternae into small vesicles and tu-
bules (Misteli and Warren, 1994), very similar to the
breakdown products seen in vivo (Lucocq et al., 1987; Mis-
teli and Warren, 1995a). Two principal fragmentation
pathways appear to be responsible for these changes. The
major fragmentation pathway, accounting for loss of 60–
70% of the cisternal membrane, is the coat protein I
(COPI)
 
1
 
 pathway, which consumes the cisternal rims by
continued budding of COPI transport vesicles in the ab-
sence of their docking and fusion (Misteli and Warren,
1994). The second COPI-independent pathway converts
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the cisternal core into heterogeneous vesicles and tubules
by a mechanism that is not yet clear (Misteli and Warren,
1995b). This pathway may be analogous to the specific
fragmentation of the Golgi complex mediated by the sea
sponge metabolite ilimaquinone (IQ) (Takizawa et al.,
1993; Jamora et al., 1999).
Mitotic Golgi fragmentation in vitro is dependent upon
Cdc2-cyclin B (Misteli and Warren, 1994; Lowe et al.,
1998). One of the Cdc2 substrates has been identified as
GM130 (Lowe et al., 1998), a protein originally identified
as part of a putative structural Golgi matrix (Nakamura
et al., 1995). GM130 is predicted to form a coiled-coil
rod with a proline-rich domain in the middle that might
form a flexible hinge (Nakamura et al., 1995). It is an-
chored to the cytoplasmic face of the cis-Golgi by its
extreme COOH terminus, which interacts tightly with
the N-myristoylated Golgi reassembly stacking protein
(GRASP) 65 (Barr et al., 1997, 1998). The NH
 
2
 
 terminus
of GM130 binds specifically to the vesicle-tethering pro-
tein p115 (Nakamura et al., 1997). p115 was originally
identified as an essential factor for intra-Golgi transport
(Waters et al., 1992), and recent studies have shown that it
can tether COPI vesicles to Golgi membranes in vitro
(Sönnichsen et al., 1998). p115 is thought to mediate teth-
ering by cross-linking GM130 on the Golgi membrane to
giantin on COPI vesicles (Sönnichsen et al., 1998). Giantin
is a type II membrane protein predicted to form a coiled-
coil rod projecting into the cytoplasm (Linstedt and Hauri,
1993; Seelig et al., 1994). Tethering mediated by p115, in a
manner analogous to that demonstrated for the yeast ho-
mologue Uso1p (Sapperstein et al., 1996; Cao et al., 1998),
is believed to bring the appropriate vesicle- and target-sol-
uble 
 
N
 
-ethylmaleimide–sensitive fusion protein (NSF) at-
tachment protein (SNAP) receptor (SNARE) proteins
into close proximity and promote the formation of trans-
SNARE pairs, which then drive membrane fusion by a
mechanism that is not well understood (Mayer, 1999).
Cdc2-mediated phosphorylation of GM130 occurs on
serine 25, with the effect of potently inhibiting p115 bind-
ing (Lowe et al., 1998). This would account for the reduced
association of p115 with Golgi membranes seen both in
vitro and in vivo (Levine et al., 1996; Shima et al., 1997),
and could explain the COPI fragmentation pathway, since
if p115 can no longer bind GM130, then COPI vesicles
would no longer be able to dock with Golgi cisternae and
so would accumulate. A role for the mitogen activated
protein kinase kinase 1 (MEK1) in mitotic Golgi fragmen-
tation has also been proposed, but the putative targets re-
main to be identified (Acharya et al., 1998).
Postmitotic reassembly of Golgi stacks occurs in two
phases: cisternal regrowth and cisternal stacking (Ra-
bouille et al., 1995b). Regrowth of cisternae in vitro can be
catalyzed by two members of the AAA (ATPases associ-
ated with diverse cellular activities) ATPase family, NSF
(and its soluble cofactors 
 
a
 
-SNAP, 
 
g
 
-SNAP and p115) or
p97 (and its soluble cofactor p47), which seem to contrib-
ute nonadditively to the growth process (Rabouille et al.,
1995a). As cisternae start to grow, they become aligned
and dock with each other to form stacks. Recent studies
have shown that p115, in addition to its role in NSF-medi-
ated cisternal growth, is also required for the initial align-
ment and docking of cisternae, acting before the stacking
 
factor GRASP65 (Shorter and Warren, 1999). The activity
of p115 in both cisternal regrowth and cisternal stacking is
dependent upon binding to its membrane tethering part-
ners, GM130 and giantin (Shorter and Warren, 1999). The
finding that p115 binding to GM130 is inhibited by phos-
phorylation of GM130 on serine 25 suggests that this resi-
due must be dephosphorylated for Golgi reassembly to oc-
cur. The identity of the phosphatases required for the
dephosphorylation of GM130, as well as other mitotic
Golgi phosphoproteins, such as GRASP65 (Barr et al.,
1997), is currently unknown.
Our current understanding of the mitotic regulation of
GM130 and its proposed role in mitotic Golgi fragmenta-
tion have come from in vitro approaches in which the
Golgi complex has one of two defined states, interphase
and mitotic. To more fully understand the involvement of
GM130 phosphorylation in mitotic fragmentation we need
to observe the phosphorylation and dephosphorylation
events as they occur in vivo. To this end, we have gener-
ated an antibody that specifically recognizes GM130 phos-
phorylated on serine 25. Here we report our findings on
the timing of GM130 phosphorylation and dephosphoryla-
tion, and link these biochemical events to the morphologi-
cal changes that take place during Golgi disassembly and
reassembly in mitosis. We also identify the trimeric form
of PP2A with the B
 
a
 
 regulatory subunit as the phos-
phatase responsible for the dephosphorylation of GM130
at the end of mitosis.
 
Materials and Methods
 
Antibodies and Reagents
 
The rabbit anti–phospho-GM130 antibody (anti–phosphoserine 25) was
raised against the phosphopeptide CQQKNpSPGVPAG (PS25pep). The
peptide was coupled to keyhole limpet hemocyanin (KLH) using glutaral-
dehyde and meta-maleimidobenzoyl N-hydroxysuccinimide ester and in-
jected into rabbits to raise polyclonal antisera. Antibodies were affinity-
purified on the phosphopeptide coupled to Ultralink Iodoacetyl beads
(Pierce Chemical Co.). Rabbit polyclonal antibodies to the NH
 
2
 
-terminal
73 amino acids of GM130 have been described previously (anti-N73pep;
Nakamura et al., 1997; Sönnichsen et al., 1998). The monoclonal anti-
GM130 antibody used in immunofluorescence experiments was purchased
from Transduction Labs. Monoclonal anti-GM130 antibody 5F10 was gen-
erated from mice immunized with full-length bacterially expressed
GM130. Rabbit antibodies to p115 (MLO-1) were raised against the
peptide ETIQKLCDRVASSTL coupled to maleimide-activated KLH
(Pierce Chemical Co.) and affinity-purified on the peptide coupled to Ul-
tralink Iodoacetyl beads. Monoclonal anti-p115 antibody (4H1) (Waters
et al., 1992) was purified from tissue culture supernatant on protein
G–Sepharose. mAbs to rat 
 
b
 
-1,4 galactosyltransferase, cyclin B1, and
 
a
 
-tubulin were kindly provided by Drs. Tatsuo Suganuma (Miyazaki
Medical College, Japan), Jonathon Pines (Wellcome/Cancer Research
Campaign Institute, Cambridge, UK), and Viki Allan (University of
Manchester, Manchester, UK), respectively. Rabbit polyclonal antibodies
to mannosidase I were kindly provided by Dr. Francis Barr (Institute of
Biomedical and Life Sciences, University of Glasgow, Glasgow, UK).
Mouse monoclonal anti-vimentin and goat polyclonal anti–lamin B anti-
bodies were purchased from Santa Cruz Biotechnology. Antibodies to
PP2A subunits were kindly provided by Drs. Brian Hemmings (Friedrich
Miescher Institute, Basel, Switzerland), Ned Lamb and Patric Turowski
(Institute of Human Genetics, Centre National de la Recherche Scienti-
fique, Montpelier, France), or purchased from Santa Cruz Biotechnology.
HRP, rhodamine, and FITC-conjugated secondary antibodies were pur-
chased from Tago Inc. Texas red– and Alexa 488–conjugated antibodies
were purchased from Molecular Probes Inc.
Purified PP1 and PP2A were purchased from Upstate Biotech. Purified
PP1 was from rabbit skeletal muscle and contained multiple PP1 isoforms.
Purified PP2A was in the trimeric form (called PP2A1) and from rabbit 
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skeletal muscle. Sf9 cell extracts with expressed PP2A isoforms were
kindly provided by Drs. Feng Gu and Gary Thomas (Vollum Institute,
Oregon Health Sciences University, Portland, OR). Okadaic acid, inhibi-
tor-2, and microcystin-LR were purchased from Calbiochem. [
 
g
 
-
 
32
 
P]ATP
was purchased from ICN Ltd. IQ and nocodazole were purchased from
Sigma Chemical Co. Hoechst 33342 and SYTO 13 were purchased from
Molecular Probes Inc. All other reagents were purchased from Sigma
Chemical Co., Boehringer Mannheim, or BDH Chemicals Ltd., unless
otherwise stated.
 
Incubation of Rat Liver Golgi Membranes with 
Interphase and Mitotic Cytosols
 
Rat liver Golgi membranes were purified as in Hui et al. (1998). Inter-
phase and mitotic cytosols were prepared from spinner HeLa cells accord-
ing to Sönnichsen et al. (1996) and desalted into buffer A (20 mM 
 
b
 
-glyc-
erophosphate, 15 mM EGTA, 50 mM KOAc, 10 mM MgOAc, 2 mM
ATP, 1 mM DTT, 0.2 M sucrose). Golgi membranes (10 
 
m
 
g) were incu-
bated with desalted cytosol (8 mg/ml) in a final volume of 50 
 
m
 
l in the
presence of an ATP regenerating system (10 mM creatine phosphate, 20
 
m
 
g/ml creatine kinase) for 30 min at 30
 
8
 
C. In some experiments, reactions
were terminated at various times by placing on ice. Membranes were re-
isolated by spinning through a layer of 0.4 M sucrose (in buffer A) for 15
min at 100,000 
 
g
 
. Membrane pellets were solubilized in SDS sample buffer
containing 5 mM NaF. For experiments where GM130 dephosphorylation
and p115 rebinding were analyzed, 10 
 
m
 
g mitotic Golgi membranes (see
below) were incubated with interphase cytosol (2 mg/ml in buffer A) sup-
plemented with 50 ng p115 (to give a p115 concentration similar to that in
mitotic cytosol) in a final volume of 50 
 
m
 
l for various lengths of time at
30
 
8
 
C. Membranes were then reisolated by centrifugation and solubilized
in SDS sample buffer containing 5 mM NaF.
 
Fractionation of Purified Rat Liver Golgi Membranes
 
50 
 
m
 
g of purified rat liver Golgi membranes (Hui et al., 1998) was adjusted
to 1.6 M sucrose (in 0.1 M KPO
 
4
 
, pH 6.7, 5 mM MgCl
 
2
 
) in a volume of 0.5
ml. This was overlaid with 1 ml 1.2 M sucrose, then 1.5 ml 1.0 M sucrose,
and finally by 1.5 ml 0.4 M sucrose (all sucrose solutions were made in 0.1 M
KPO
 
4
 
, pH 6.7, 5 mM MgCl
 
2
 
), and centrifuged for 4 h at 55,000 rpm in an
SW55 rotor. Fractions (0.4 ml) were collected from the top, 40 
 
m
 
g soybean
trypsin inhibitor added as a carrier, and proteins precipitated using metha-
nol/chloroform. Precipitated proteins were solubilized in SDS sample
buffer and analyzed by SDS-PAGE.
 
Drug Treatments and Cell Synchronization
 
Normal rat kidney (NRK) and HeLa cells were maintained in DME con-
taining 10% FCS. Cells were incubated with okadaic acid (1 
 
m
 
M) for 1 h at
37
 
8
 
C, or with IQ (25 
 
m
 
M) for 2 h at 37
 
8
 
C. Cells were first chilled to 4
 
8
 
C for
5 min before incubation with nocodazole (5 
 
m
 
g/ml) for 2 h at 37
 
8
 
C. For en-
richment of mitotic NRK cells, 2.5 
 
m
 
g/ml aphidicolin was added to the me-
dium for 12–14 h to arrest cells at the G1/S boundary. Cells were washed
several times to remove the drug and incubated in fresh medium for 5–6 h
to allow progression into mitosis.
 
Preparation of Cell Lysates and Immunoprecipitation
of GM130
 
Mitotic NRK cells were removed from culture dishes by repeated flushing
with a Pasteur pipette and collected by centrifugation. Cells were washed
with ice-cold PBS and lysed in lysis buffer (20 mM Hepes, pH 7.4, 100 mM
KCl, 10% glycerol, 0.5% Triton X-100, 5 mM EDTA, 2 mM EGTA, 10
mM NaF, 40 mM 
 
b
 
-glycerophosphate, 1 mM sodium orthovanadate) con-
taining protease inhibitors (1 mM PMSF, 0.5 mM 1-10 phenanthroline, 2
 
m
 
M pepstatin, 2 
 
m
 
g/ml aprotinin, 4 
 
m
 
g/ml aprotinin, 20 
 
m
 
g/ml chymostatin)
for 10 min on ice before centrifugation at 20,000 
 
g
 
 for 10 min. Clarified ly-
sates were frozen in liquid nitrogen and stored at 
 
2
 
80
 
8
 
C. Protein concen-
tration was measured using the BCA method (Pierce Chemical Co.). For
analysis by Western blotting, proteins were precipitated with 10% TCA
and resuspended in SDS sample buffer. For immunoprecipitation of
GM130, 200 
 
m
 
l of lysate (100 
 
m
 
g protein) was incubated with 50 
 
m
 
l of 5F10
hybridoma culture supernatant for 1 h at 4
 
8
 
C, before addition of 20 
 
m
 
l pro-
tein G–Sepharose beads (50% slurry) and incubation for a further 1 h at
4
 
8
 
C. Beads were washed three times with lysis buffer, once with PBS, and
proteins eluted by boiling in 2
 
3
 
 SDS sample buffer.
 
Fluorescence Microscopy
 
Cells were grown on glass coverslips and fixed in 100% methanol (
 
2
 
20
 
8
 
C)
for 4 min. In some cases, cells were fixed in paraformaldehyde (3.5% in
PBS) for 20 min at room temperature, quenched with 10 mM glycine, pH
8.5 (in PBS), and permeabilized with 0.1% Triton X-100 (in PBS) for 5
min at room temperature. Coverslips were incubated with primary anti-
bodies diluted in PBS containing 0.5 mg/ml BSA for 20 min at room tem-
perature, washed with PBS, and incubated with rhodamine-, Texas red–,
FITC-, or Alexa 488–conjugated secondary antibodies diluted in PBS con-
taining 0.5 mg/ml BSA for a further 20 min at room temperature. The
DNA dye Hoechst 33342 (200 ng/ml) was included in the second incuba-
tion to allow identification of mitotic stages. For visualization of DNA
with SYTO 13, methanol-fixed cells were incubated with 1 mg/ml DNAse-
free RNAse (in PBS) for 1 h at room temperature before labeling. SYTO
13 was included in the second incubation at 500 nM. Coverslips were
mounted in Mowiol, allowed to dry, and viewed by laser scanning confocal
microscopy on a Zeiss LSM510 confocal microscope. Serial optical sec-
tions (collected at 0.45-
 
m
 
m intervals) in the z-axis of the cell were col-
lected and overlaid for the final images shown.
Quantitation of images was performed with the Metamorph program
(Universal Imaging Corp.). The total cellular fluorescence of GM130-con-
taining structures was calculated using conflated series of sections through
entire cells. Background was subtracted and a threshold introduced to ex-
clude diffuse cytoplasmic staining. All pixels above this threshold value
were counted as GM130-containing structures in both interphase and mi-
totic cells. The results were expressed as the mean 
 
6 
 
SD/cell and normal-
ized to interphase cells. The mean fluorescence intensities for GM130 and
p115 were measured for a total of 40 different selected Golgi (GM130-
positive) areas in four different interphase and metaphase cells. These ar-
eas corresponded to the Golgi ribbon in interphase cells and individual
mitotic clusters in metaphase cells. The ratio of GM130 to p115 fluores-
cence was calculated for each area. The ratios were then averaged and ex-
pressed as the mean 
 
6 
 
SD, and normalized to interphase cells.
 
Dephosphorylation Assays
 
Mitotic Golgi membranes were prepared by incubating rat liver Golgi
membranes (1 mg) with mitotic HeLa cytosol (5 ml at 2 mg/ml in Buffer A
with an ATP-regenerating system) for 30 min at 30
 
8
 
C. Membranes were
reisolated by centrifugation for 20 min at 100,000 
 
g
 
 in a SW55 rotor (Beck-
man Instruments) through a layer of 0.4 M sucrose in dephosphorylation
buffer (20 mM Hepes, pH 7.4, 50 mM KOAc, 1 mM EGTA, 1 mM DTT),
onto a 2 M sucrose cushion. Membranes were resuspended at 2 mg/ml in
dephosphorylation buffer containing 0.2 M sucrose and stored at 
 
2
 
80
 
8
 
C.
 
32
 
P-labeled phosphorylase a was prepared by incubating phosphorylase b
(10 mg/ml) with phosphorylase kinase (300 
 
m
 
g/ml) and 0.4 mM [
 
g
 
-
 
32
 
P]
ATP (750 
 
m
 
Ci/ml) in 75 mM 
 
b
 
-glycerophosphate, pH 8.6, 0.2 mM CaCl
 
2
 
, 2
mM MgOAc, for 1 h at 30
 
8
 
C. Free ATP was removed by spinning through
two Biogel P6-DG (Biorad) spin columns previously equilibrated in 50
mM Tris, pH 7.4, and the protein stored at 4
 
8
 
C. All dephosphorylation ex-
periments were carried out in dephosphorylation buffer containing 0.2 M
sucrose and 0.2 mg/ml BSA. 5 mM caffeine was included when phosphory-
lase a was the substrate. 1 
 
m
 
g N73pepPS25 or 5 
 
m
 
g mitotic Golgi mem-
branes was incubated with interphase cytosol, purified phosphatase, or Sf9
cell lysate in a final volume of 25 
 
m
 
l for 20 min at 30
 
8
 
C. Sf9 cell lysates,
prepared according to Molloy et al. (1998), were diluted 1:50 before addi-
tion to the assay. In experiments with phosphatase inhibitors, 0.01% Brij-
35 was included. When phosphorylase a was the substrate, proteins were
precipitated with TCA and [
 
32
 
P]phosphate in the supernatant measured
by liquid scintillation counting. In experiments with N73pepPS25, 2 
 
m
 
M
microcystin-LR was added at the end of the incubation and 1 
 
m
 
l of the re-
action mix was spotted onto nitrocellulose. In experiments with Golgi
membranes, samples were centrifuged for 15 min at 45,000 rpm in a
TLA45 rotor (Beckman Instruments) and the pelleted membranes solubi-
lized in SDS sample buffer containing 5 mM NaF.
 
SDS-PAGE, Western, and Dot Blotting
 
Proteins were separated by SDS-PAGE on 8 or 10% gels and transferred
to nitrocellulose membrane (Hybond C; Amersham Pharmacia Biotech)
by semidry blotting. For dot blots, proteins were pipetted directly onto ni-
trocellulose. Membranes were blocked in milk buffer (5% non-fat milk
powder, 0.2% Tween-20 in PBS) before incubation with primary antibod-
ies diluted in milk buffer. HRP-conjugated goat anti–rabbit or anti–mouse
antibodies (1:2,000) were used to detect primary antibodies. Bands were 
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visualized by Enhanced Chemi-Luminescence (ECL; Amersham Pharma-
cia Biotech).
 
Results
 
Antibodies to Mitotically Phosphorylated GM130
 
We showed previously that GM130 is phosphorylated in
mitosis and that phosphorylation inhibits binding to the
vesicle-tethering protein, p115 (Nakamura et al., 1997).
Mitotic phosphorylation is mediated by Cdc2-cyclin B and
takes place on serine 25 (Lowe et al., 1998). To study
the phosphorylation of GM130 in more detail, we gener-
ated rabbit polyclonal antibodies to a synthetic peptide
(PS25pep; CQQKNpSPGVPAG) containing residues 21–
31 of GM130, in which the serine 25 residue was phosphor-
ylated. Antibodies were purified on the phosphopeptide
and used to study phosphorylation of GM130 by West-
ern blotting and immunofluorescence microscopy. The
purified antibodies (designated anti–phosphoserine 25 or
PS25) detected a single band of 
 
z
 
130 kD on Western blots
of mitotically-treated Golgi membranes, whereas no label-
ing of interphase-treated Golgi membranes was observed
(Fig. 1 A, left panel). An 
 
z
 
130-kD band was also detected
on Western blots of mitotic but not interphase NRK cell
lysates (Fig. 1 A, middle panel). To confirm this was mitot-
ically phosphorylated GM130 and not another cross-react-
ing 130-kD protein, GM130 was immunoprecipitated from
the cell lysates using a specific mAb before analysis by
Western blotting. The PS25 antibodies recognized an
 
z
 
130-kD band in immunoprecipitates from mitotic but
not interphase NRK cells (Fig. 1 A, right panel), confirm-
ing that the antibodies recognize mitotically phosphory-
lated GM130. The specificity of the PS25 antibody was
further confirmed in competition experiments with the
phosphorylated peptide PS25pep or a nonphosphorylated
version of the same peptide. PS25pep abolished reactivity
of the PS25 antibodies to the 
 
z
 
130-kD GM130 band,
whereas the nonphosphorylated peptide had no effect
(Fig. 1 B, upper panel). Reactivity of another antibody
that recognizes the NH
 
2
 
 terminus of both nonphosphory-
lated and phosphorylated GM130 was not affected by ei-
ther peptide (Fig. 1 B, lower panel).
The PS25 antibody was next tested for its ability to rec-
ognize GM130 in mitotic cells by immunofluorescence mi-
croscopy. NRK cells were fixed in methanol and labeled
with antibodies to phosphoserine 25 and 
 
b
 
-1,4 galactosyl-
transferase, a resident enzyme of the Golgi complex. Mi-
totic cells were identified using the DNA dye Hoechst
33342. Serial optical sections were sampled using a laser
scanning confocal microscope, and the sections overlaid
and visualized in two dimensions. As shown in Fig. 2 A,
PS25 antibodies labeled the Golgi complex of cells in the
prometaphase stage of mitosis, whereas there was no la-
beling of cells in interphase. Labeling was not dependent
upon fixation method, since PS25 antibodies also labeled
the Golgi complex in paraformaldehyde-fixed mitotic cells
(data not shown). PS25 antibodies also labeled the Golgi
complex in mitotic but not interphase HeLa cells (see Fig.
3 B), confirming that phosphorylation of serine 25 is con-
served between species. Golgi labeling with PS25 antibod-
ies was efficiently competed by the PS25pep phosphopep-
tide and not affected by the nonphosphorylated version of
this peptide (Fig. 2 A).
 
Phosphorylation of GM130 at Different Stages
of Mitosis
 
NRK cells at different stages of mitosis were fixed in
methanol and double-labeled with antibodies to phospho-
serine 25 and the nucleic acid stain SYTO 13. Mitotic
stages were identified by the SYTO 13–labeled DNA.
Phosphorylation of GM130 occurs early in mitosis, during
prophase (Fig. 2, B–D). Counting of prophase cells re-
Figure 1. Specificity of the anti-phosphoserine 25 antibodies by
Western blotting. (A) Left panel: Rat liver Golgi membranes
were incubated with interphase (I) or mitotic (M) cytosol, reiso-
lated by centrifugation, solubilized in SDS sample buffer, and
subjected to Western blotting with antibodies against phospho-
serine 25 (PS25) or the NH2 terminus of GM130 (GM130). Mid-
dle panel: Interphase (I) or mitotic (M) NRK cells were lysed in
buffer containing Triton X-100, and solubilized proteins analyzed
by Western blotting with antibodies against phosphoserine 25
(PS25) or the NH2 terminus of GM130 (GM130). The asterisk
denotes a cross-reacting protein of unknown identity found in in-
terphase and mitotic lysates. Right panel: GM130 was immuno-
precipitated (IP) from Triton X-100 solubilized interphase (I)
and mitotic (M) NRK cells with a monoclonal anti-GM130 anti-
body before analysis by Western blotting with antibodies against
phosphoserine 25 (PS25) or the NH2 terminus of GM130
(GM130). Molecular mass markers are shown in kD. (B) Mitotic
Golgi membranes were analyzed by Western blotting with anti-
bodies to phosphoserine 25 (PS25) or the NH2 terminus of
GM130 (GM130) in the absence or presence of the indicated mo-
lar excess of the phosphoserine 25 (PS25pep) or unphosphory-
lated (nonPSpep) peptide. GM130 appears as a doublet, most
likely due to proteolytic cleavage. 
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vealed that 57% (
 
n
 
 5 
 
130) were positive for phospho-
serine 25, suggesting that phosphorylation occurs around
the middle of prophase. Labeling intensity for phospho-
GM130 appeared to increase in proportion to the level of
chromatin condensation, with late prophase cells (with
highly condensed chromatin) showing the strongest label-
ing (Fig. 2 C). Double-labeling with antibodies to lamin B
showed that phosphorylation of GM130 occurs before nu-
clear envelope breakdown (Fig. 3 A). Phosphorylation is
maintained as the nuclear envelope disassembles during
transit through late prophase into prometaphase (Fig. 3
A). Double-labeling of HeLa cells with antibodies to phos-
phoserine 25 and cyclin B1 revealed a close temporal rela-
tionship between GM130 phosphorylation and translo-
cation of cyclin B1 into the nucleus (Fig. 3 B). 77% of
PS25-positive prophase cells (
 
n
 
 5 
 
150) had cyclin B1 in the
nucleus. Cells with nuclear cyclin B1 tended to exhibit
stronger labeling with phosphoserine 25 antibodies com-
pared with those cells with predominantly cytoplasmic cy-
clin B1 (Fig. 3 B), suggesting that phosphorylation contin-
ues to occur as cyclin B1 is translocated into the nucleus.
The finding that all cells with nuclear cyclin B1 were posi-
tive for PS25 (
 
n
 
 5 
 
100) is consistent with this. Phosphory-
lation of serine 25 is maintained during prometaphase,
metaphase, and anaphase, during which time the Golgi is
broken down into smaller dispersed fragments (Fig. 2, B
and D). Reactivity against phosphoserine 25 is lost during
telophase, coinciding with the congregation of the parti-
tioned Golgi fragments and their coalescence into larger
Golgi elements (Fig. 2, B and D). GM130 is therefore
phosphorylated in prophase as the Golgi complex starts to
break down, and dephosphorylated in telophase as the mi-
totic Golgi fragments start to reassemble.
Double-labeling with anti-GM130 antibodies showed
that almost all the dispersed fragments containing GM130
were phosphorylated on GM130 (Fig. 2 D). The amount of
GM130 in these fragments was also quantitated, since it
has been suggested that they disperse almost completely
during metaphase through early telophase, the dispersed
fragments fusing with the ER (Zaal et al., 1999). As shown
in Table I, we did find that the amount of GM130 in identi-
fiable fragments fell from metaphase through early telo-
phase, but the level only fell to 
 
z
 
50%, not the 2% re-
ported by Zaal et al. (1999) for 
 
b
 
1,4-galactosyltransferase
and other Golgi markers, including GM130.
 
Phosphorylation of GM130 and Binding of p115 to
Golgi Membranes
 
In vitro experiments have shown previously that mitotic
phosphorylation of GM130 inhibits binding to the vesicle-
tethering factor p115 (Nakamura et al., 1997). In agree-
ment with this, immunofluorescence analysis showed that
p115 was largely absent from mitotic Golgi clusters in
HeLa cells (Shima et al., 1997). To investigate the tempo-
ral relationship between the phosphorylation of GM130
and the dissociation of p115 from the Golgi complex, cells
were double-labeled with antibodies to phosphoserine 25
and p115 (Fig. 4 A). Dissociation of p115 at different mi-
totic stages was also monitored by double-labeling cells
with antibodies to total GM130 and p115 (Fig. 4 B). In in-
terphase cells, p115 gave a typical perinuclear Golgi label-
ing in addition to numerous punctate structures corre-
sponding to the intermediate compartment as reported
previously (Nelson et al., 1998). As cells enter prophase
and GM130 is phosphorylated, the p115 distribution starts
to change. There is a marked increase in the number of
p115-positive and GM130-negative punctate structures
around the Golgi region, and there is an increase in the
amount of soluble p115, observed as a diffuse cytoplasmic
staining (Fig. 4, A and B). By the time cells reach
prometaphase, the amount of Golgi-associated p115 has
dramatically reduced, and there is a corresponding in-
crease in diffuse cytoplasmic p115 staining (Fig. 4, A and
B). In metaphase, little p115 remains associated with mi-
totic clusters (Fig. 4 B, compare green [GM130-positive]
clusters in the metaphase cell with the yellow [GM130-
and p115-positive] Golgi in the adjacent interphase cell),
an observation confirmed by quantitation. As shown in
Table II, 78% of the p115 found on interphase GM130-
containing Golgi membranes had dissociated by meta-
phase. Since most of the GM130 in the metaphase cells
was present in identifiable fragments (72% in this experi-
ment), this means that most of the p115 on interphase
membranes had dissociated by metaphase. The small
amount of residual p115 binding (22% of that found in in-
terphase) could be to another p115-binding protein on the
Golgi complex such as giantin, or it could be to intermedi-
ate compartment membranes, which lack GM130, in close
proximity to the mitotic Golgi membranes.
The correlation between GM130 phosphorylation and
dissociation of p115 from Golgi membranes was also stud-
 
Table I. Quantitation of GM130-containing Structures at 
Different Mitotic Stages
 
Stage
Total cellular fluorescence of
GM130-containing structures
 
Interphase (1) 
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 0.22 (
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 31)
Prophase 1.03 
 
6
 
 0.19 (
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 10)
Prometaphase 1.00 
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 0.32 (
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 7)
Metaphase 0.52 
 
6
 
 0.18 (
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 11)
Anaphase 0.52 
 
6
 
 0.27 (
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 9)
Early telophase 0.57 
 
6
 
 0.19 (
 
n
 
 
 
5
 
 8)
Late telophase/cytokinesis 1.03 
 
6
 
 0.24 (
 
n
 
 
 
5
 
 8)
 
NRK cells were labeled with antibodies to GM130 and imaged by confocal micros-
copy. Quantitation was performed as detailed in Materials and Methods. The total cel-
lular fluorescence of GM130-containing structures in interphase and mitotic cells is
expressed in arbitrary units as the mean 
 
6
 
 SD (
 
n
 
 
 
5
 
 7–31) and normalized to give an
interphase value of 1.
Table II. Quantitation of Golgi-associated GM130 and p115 in 
Interphase and Metaphase Cells
Stage
Total cellular fluorescence of
GM130-containing structures
Ratio of p115 to GM130 on
GM130-containing structures
Interphase (1) 6 0.13 (1) 6 0.21
Metaphase 0.72 6 0.10 0.22 6 0.05
NRK cells were double-labeled with antibodies to GM130 and p115 and imaged by
confocal microscopy. Quantitation was performed as detailed in Materials and Meth-
ods. The total cellular fluorescence of GM130-containing structures in interphase and
metaphase cells is expressed in arbitrary units as the mean 6 SD (n 5 7) and normal-
ized to give an interphase value of 1. The ratio of p115 to GM130 on GM130-contain-
ing structures was determined for interphase and metaphase cells from the mean fluo-
rescent intensities of p115 and GM130 in the same selected areas of GM130-positive
structures. Values are expressed in arbitrary units as the mean 6 SD (n 5 40) and nor-
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ied in vitro. Rat liver Golgi membranes were incubated for
various lengths of time with mitotic cytosol, reisolated
through a sucrose cushion, and analyzed by Western blot-
ting for the phosphorylation of serine 25 and the amount
of membrane-associated p115. Phosphorylation of GM130
was rapid, already apparent at 2 min, and complete at 5–10
min (Fig. 4 C). Dissociation of p115 proceeded with very
similar kinetics, and there was a good inverse relationship
between the amount of GM130 phosphorylation and the
amount of membrane-associated p115 (Fig. 4 C). No
GM130 phosphorylation occurred with interphase cytosol,
and although there was some dissociation of p115 from the
Golgi membranes, it was much less than that observed
during mitotic incubations.
Since GM130 is dephosphorylated during telophase, we
might expect rebinding of p115 to occur at this stage, espe-
cially if it is important for Golgi reassembly. There are low
amounts of p115 bound to mitotic Golgi clusters through
anaphase to early telophase (Fig. 4 B). By late telophase,
however, p115 binding is restored to interphase levels. As
shown in Fig. 4 A, lower panel, rebinding of p115 corre-
lates well with GM130 dephosphorylation. The telophase
cell at the bottom of the field, in which GM130 is still
phosphorylated, has a low amount of Golgi-associated
p115, whereas the cell at the top, where GM130 has been
dephosphorylated, has much more p115 bound. The link
between dephosphorylation of GM130 and rebinding of
p115 to Golgi membranes was also studied in vitro. Mi-
totic Golgi membranes with phosphorylated GM130 and
little bound p115, were incubated with interphase cytosol
for various lengths of time, and the dephosphorylation of
GM130 and binding of p115 to the membranes analyzed
by Western blotting. As shown in Fig. 4 D, dephosphoryla-
tion of GM130 correlated well with membrane binding of
p115.
Drug-induced Golgi Fragmentation and 
Phosphorylation of GM130
The Golgi complex fragments in cells treated with the pro-
Figure 2 (continues on facing page).Lowe et al. Mitotic Phosphorylation and Dephosphorylation of GM130 347
Figure 2. Mitotic phosphorylation of GM130 analyzed by immunofluorescence microscopy. (A) Specificity of the anti-PS25 antibodies.
Methanol-fixed NRK cells were double-labeled with antibodies to phosphoserine 25 (PS25) and b-1,4 galactosyltransferase (GalT) in
the absence (upper panel) or presence of a 100-fold molar excess of the phosphoserine 25 (PS25pep, middle panel) or unphosphorylated
(nonPSpep, lower panel) peptide. Representative cells in interphase (indicated by an asterisk) and prometaphase (unmarked) are
shown. Bar, 20 mm. (B) Phosphorylation of GM130 at different stages of mitosis. NRK cells were synchronized to enrich for mitotic
cells, fixed in methanol, and double-labeled with antibodies to phosphoserine 25 (PS25) and the nucleic acid stain SYTO 13 (DNA) to
identify mitotic stages. The cell in the bottom panel is a later stage of telophase than the cell in the panel directly above. Interphase cells
are marked by an asterisk. Bar, 20 mm. (C) GM130 phosphorylation in prophase. Synchronized NRK cells were fixed in methanol and
double-labeled with antibodies to phosphoserine 25 (PS25) and the nucleic acid stain SYTO 13 (DNA). The upper panel shows a G2
cell with no chromatin condensation. The middle two panels show prophase cells with condensed chromatin that are either negative or
positive for PS25. The bottom panel shows a late prophase cell with highly condensed chromatin which is PS25 positive. Bar, 20 mm. (D)
Phosphorylation of GM130 and Golgi division in mitosis. NRK cells were synchronized to enrich for mitotic cells, fixed in methanol,
and double-labeled with antibodies to phosphoserine 25 (PS25) and total GM130 (GM130). Mitotic stages were determined using the
DNA binding dye Hoechst 33342. Interphase cells are marked by an asterisk. Bar, 20 mm.The Journal of Cell Biology, Volume 149, 2000 348
tein phosphatase inhibitor okadaic acid, yielding numer-
ous clusters of Golgi-derived vesicles and tubules morpho-
logically very similar to those seen in mitosis (Lucocq et
al., 1991). This has led to the proposal that okadaic acid
mimics mitotic Golgi fragmentation by activating the same
breakdown pathway as that used in mitosis (Lucocq,
1992). We therefore investigated whether okadaic acid in-
duces phosphorylation of GM130 on serine 25 and dissoci-
ation of p115 from Golgi membranes. As shown in Fig. 5
A, treatment of NRK cells with 1 mM okadaic acid led to
Golgi fragmentation, but GM130 was not phosphorylated
on serine 25, and p115 remained bound to the Golgi frag-
ments. Similar results were obtained with HeLa cells, ex-
cept the Golgi fragments were more numerous and more
dispersed (data not shown). Similar results were also ob-
tained in vitro. Purified Golgi membranes were incubated
with interphase or mitotic cytosol in the absence or pres-
ence or 1 mM okadaic acid, which has been shown to frag-
ment Golgi membranes in vitro (Misteli and Warren,
1994), and analyzed for phosphorylation of GM130 on
serine 25 and membrane association of p115. As shown in
Fig. 5 B, okadaic acid had no effect upon serine 25 phos-
phorylation or p115 membrane association. In contrast,
PS25 was efficiently phosphorylated by mitotic cytosol and
p115 dissociated from the membranes (Fig. 5 B).
IQ triggers Golgi fragmentation through a mechanism
involving Gbg-mediated activation of protein kinase D
(PKD) (Takizawa et al., 1993; Jamora et al., 1999). NRK
cells were incubated with 25 mM IQ for 2 h and the phos-
phorylation of serine 25 analyzed by immunofluorescence
microscopy. Golgi fragments generated by IQ were not la-
beled with anti–phosphoserine 25 antibodies and p115 re-
mained bound to the Golgi fragments (Fig. 5 C). NRK
cells were also treated with nocodazole, a drug that depo-
lymerizes microtubules and converts the Golgi ribbon into
mini-stacks dispersed throughout the cytoplasm (Thyberg
and Moskalewski, 1989). Nocodazole-generated Golgi
fragments were not labeled with phosphoserine 25 anti-
bodies, and p115 remained associated with these Golgi
fragments as reported previously (Shima et al., 1997) (Fig.
5 C). Phosphorylation of GM130 on serine 25 and dissocia-
tion of p115 from Golgi membranes are therefore specific
for mitosis, suggesting that Golgi fragmentation in mitosis
occurs by a different mechanism, or one acting in parallel
to that induced by okadaic acid, IQ, and nocodazole.
Dephosphorylation of Mitotically Phosphorylated 
GM130 by PP2A
Cdc2-cyclin B has been identified as the mitotic GM130 ki-
nase (Lowe et al., 1998). However, which phosphatase de-
phosphorylates mitotic GM130 in telophase is not known.
To identify the GM130 phosphatase, an assay was devel-
oped to measure GM130 dephosphorylation in vitro. Two
substrates were used for these experiments: one was a
peptide comprising the NH2-terminal 73 amino acids of
Figure 3. Mitotic phosphorylation of GM130 precedes nuclear envelope breakdown and coincides with nuclear translocation of cyclin
B1. (A) Phosphorylation of GM130 before nuclear envelope breakdown. Methanol-fixed NRK cells were double-labeled with antibod-
ies to phosphoserine 25 (PS25) and lamin B. Examples of cells with phosphorylated GM130 and an intact (upper panel), partially disas-
sembled (middle panel), and fully disassembled (lower panel) nuclear envelope are shown. Interphase cells are marked with an asterisk.
Bar, 20 mm. (B) Phosphorylation of GM130 and translocation of cyclin B1 into the nucleus. Methanol-fixed HeLa cells were double-
labeled with antibodies to phosphoserine 25 (PS25) and cyclin B1. Upper panel: a prophase cell with phosphorylated GM130 and cyclin
B1 in the nucleus is shown on the left. A G2 cell, negative for phospho-GM130 and with cytoplasmic cyclin B1 is on the right. Lower
panel: a prophase cell that is PS25-positive with predominantly cytoplasmic cyclin B1 is shown. Bar, 20 mm.Lowe et al. Mitotic Phosphorylation and Dephosphorylation of GM130 349
GM130 synthesized with a phosphoserine at position 25
(N73pepPS25), and the second was native mitotically phos-
phorylated GM130, prepared by incubating Golgi mem-
branes with mitotic cytosol. Each substrate was incubated
with cytosol prepared from interphase HeLa cells, and de-
phosphorylation monitored by loss of reactivity to the
phosphoserine 25 antibodies. The PS25 antibodies reacted
strongly with N73pepPS25 phosphopeptide, but not with
the same peptide lacking a phosphate group on serine 25
(Fig. 6 A, upper left panel). Reactivity was lost when the
phosphopeptide was incubated with increasing concentra-
tions of HeLa cytosol (Fig. 6 A, upper right panel). This
Figure 4. Phosphorylation of GM130 in mitosis correlates
with dissociation of p115 from Golgi membranes. (A) Phos-
phorylation of GM130 and dissociation of p115 from Golgi
membranes in vivo. Methanol-fixed NRK cells were double-
labeled with antibodies to phosphoserine 25 (PS25) and p115.
The top three panels show cells in prophase, prometaphase, or
metaphase, and include an interphase cell (marked with an as-
terisk) for comparison. In the bottom panel, two cells are
shown, one in early telophase (bottom) and one in late telo-
phase (top). Bar, 20 mm. (B) Dissociation of p115 from Golgi
membranes in vivo. Methanol-fixed NRK cells were double-
labeled with antibodies against total GM130 and p115. Images are depicted as overlays of GM130 (green) and p115 (red), with regions
of overlap indicated by yellow. Interphase cells are marked with an asterisk. Bar, 20 mm. (C) Phosphorylation of GM130 and dissocia-
tion of p115 from Golgi membranes in vitro. Rat liver Golgi membranes were incubated in buffer alone or in mitotic or interphase cyto-
sol for the times indicated, and reisolated by centrifugation before solubilization in SDS sample buffer and analysis by Western blotting
with antibodies to phosphoserine 25 (PS25) or p115. (D) Dephosphorylation of GM130 and reassociation of p115 with Golgi mem-
branes in vitro. Mitotic Golgi membranes were incubated in buffer alone or in interphase cytosol supplemented with 50 ng exogenous
p115 for the times indicated, and reisolated by centrifugation before solubilization in SDS sample buffer and analysis by Western blot-
ting with antibodies to phosphoserine 25 (PS25) or p115.The Journal of Cell Biology, Volume 149, 2000 350
was due to dephosphorylation and not degradation, since
reactivity to anti-N73pep antibodies was not affected. Simi-
lar results were obtained with native GM130 on mitotic
Golgi membranes. GM130 was dephosphorylated by inter-
phase HeLa cytosol at similar concentrations to that ob-
served for the phosphopeptide (Fig. 6 A, lower panel).
Four major classes of protein phosphatase have been
identified in mammalian cells: PP1, PP2A, PP2B, and
PP2C (for reviews see Cohen, 1989; Shenolikar, 1994).
Differences in substrate specificity, divalent cation re-
quirement, and sensitivity to various inhibitors can be used
to distinguish between these phosphatases (Cohen, 1991).
Inhibitor studies with microcystin and okadaic acid have
shown that most of the serine/threonine phosphatase ac-
tivity in the cell is attributable to PP1 and PP2A (Cohen,
1991). Interestingly, both phosphatases have been linked
to mitotic events (Axton et al., 1990; Kinoshita et al., 1990;
Mayer-Jaekel et al., 1993; Tournebize et al., 1997). We
therefore decided to investigate whether PP1 or PP2A can
dephosphorylate mitotic GM130. Both PP1 and PP2A are
inhibited by okadaic acid, but with different sensitivities
(Bialojan and Takai, 1988; Cohen, 1991). PP2A is inhib-
ited at a 100-fold lower okadaic acid concentration than
PP1, with an IC50 (concentration yielding 50% inhibition)
of 0.1 nM compared with an IC50 of 10–15 nM for PP1. As
shown in Fig. 6 B, dephosphorylation of the N73pepPS25
phosphopeptide was sensitive to low concentrations of
okadaic acid (IC50 of z0.1 nM). Similar results were ob-
tained with native phospho-GM130 on mitotic Golgi
membranes (IC50 of z0.1–0.5 nM), suggesting that PP2A
dephosphorylates GM130. To characterize this further, ex-
periments were performed with protein phosphatase in-
hibitor-2, which inhibits PP1 with an IC50 of 2 nM but has
no effect upon PP2A (Cohen, 1991). Dephosphorylation
of both the GM130 phosphopeptide and native GM130
was insensitive to inhibitor-2 at concentrations up to 500
Figure 5. Drug-induced Golgi fragmentation independent of GM130 phosphorylation. (A) Golgi fragmentation with okadaic acid.
NRK cells were treated with 1 mM okadaic acid for 1 h and double-labeled with antibodies to phosphoserine 25 (PS25) and total GM130
(upper panel), or p115 and GM130 (lower panel). Bar, 20 mm. (B) Immunoblotting of GM130 and p115 after okadaic acid treatment in
vitro. Golgi membranes were incubated with interphase or mitotic cytosol for 2 or 20 min at 308C in the absence or presence of 1 mM
okadaic acid and subjected to Western blotting with antibodies to phosphoserine 25 (PS25) or p115. (C) Golgi fragmentation with IQ or
nocodazole. NRK cells were treated with 25 mM IQ (upper panels) or 5 mM nocodazole (noc; lower panels) for 2 h and double-labeled
with antibodies to PS25 and GM130 or p115 and GM130. Bar, 20 mm.Lowe et al. Mitotic Phosphorylation and Dephosphorylation of GM130 351
nM (Fig. 6 C, lanes 5–7), whereas it was completely inhib-
ited by 1 nM okadaic acid in the same experiment (Fig. 6
C, lane 4), suggesting again that the GM130 phosphatase is
PP2A and not PP1. To obtain additional evidence that
PP2A is the GM130 phosphatase, dephosphorylation reac-
tions were carried out with purified PP1 and PP2A. Equal
amounts of phosphatase activity (assayed using phos-
phorylase a as the substrate) were added in each case. As
shown in Fig. 7, only PP2A dephosphorylated the GM130
phosphopeptide and native mitotic GM130 on Golgi mem-
branes.
PP2A exists as a trimeric complex in vivo, with a con-
stant dimeric core of a 36-kD catalytic (PP2Ac or C) sub-
unit and a 65-kD (PR65 or A) subunit bound to a third,
variable B subunit (Mayer-Jaekel and Hemmings, 1994;
Millward et al., 1999). Three classes of B subunit have so
far been identified: B/PR55, B9/PR61, and B99/PR72,
PR130, or PR59. The B subunits have been shown to act as
positive regulators to enhance catalytic activity toward
particular substrates both in vitro and in vivo (Ferrigno et
al., 1993; Mayer-Jaekel et al., 1994; Sontag et al., 1996;
Zhao et al., 1997; Turowski et al., 1999). Furthermore, the
distinct subcellular localization of the B subunits may act
to target isoforms of PP2A to particular locations in the
cell (Sontag et al., 1995; McCright et al., 1996; Turowski et
al., 1999). To test whether the B subunit of PP2A plays a
role in modulating the activity of PP2A towards GM130,
the strategy of phosphatase isoform reconstitution by bac-
ulovirus infection was employed (Kamibayashi et al.,
1994). Sf9 cells were coinfected with baculovirus recombi-
nants expressing combinations of the C, A, and one of the
variable B subunits, and lysates assayed for their ability to
dephosphorylate GM130 in vitro. There was some GM130
phosphatase activity in uninfected cell lysates (Fig. 8 A,
none), most likely due to endogenous PP2A. This was not
increased by expression of the AC dimer (Fig. 8 A). Coex-
pression of the Ba subunit with AC dramatically increased
the GM130 phosphatase activity (Fig. 8 A). Activity
towards the phosphopeptide was increased z15-fold and
activity towards GM130 on Golgi membranes increased
z10-fold. In contrast, coexpression of the B9a subunit
with AC did not increase GM130 phosphatase activity. In
fact, the B9a subunit slightly inhibited basal activity to-
wards GM130 (Fig. 8 A), most likely by displacing endoge-
nous Sf9 cell B family subunits from holoenzyme com-
plexes (Tehrani et al., 1996). Each lysate exhibited similar
Figure 6. Dephosphorylation of mitotic GM130 is sensitive to low concentrations of okadaic acid. (A) Dephosphorylation of GM130 by
interphase cytosol. Upper panel: N73pepPS25, the NH2-terminal GM130 peptide with phosphoserine at position 25, was incubated with
increasing amounts of interphase cytosol at 308C, before spotting onto nitrocellulose and probing with antibodies against phosphoserine
25 (PS25) or the whole NH2-terminal peptide (N73pep). The panel on the left shows an equivalent spot of the NH2-terminal peptide
with a nonphosphorylated serine at position 25. Lower panel: Mitotically-treated Golgi membranes were incubated with increasing
amounts of interphase cytosol, solubilized in SDS sample buffer, and analyzed by Western blotting with antibodies to phosphoserine 25
(PS25) or mannosidase I (Mann-1). (B) Sensitivity of the GM130 phosphatase to okadaic acid. Upper panel: The N73pepPS25 peptide
was incubated in the absence of cytosol (2) or with 20 mg/ml interphase cytosol in the presence of increasing amounts of okadaic acid.
Dephosphorylation was monitored by blotting with antibodies to phosphoserine 25 (PS25) or the whole peptide (N73pep). Lower
panel: Mitotic Golgi membranes were incubated in the absence of cytosol (2) or with 20 mg/ml interphase cytosol in the presence of in-
creasing amounts of okadaic acid. The membranes were then solubilized in SDS sample buffer and analyzed by Western blotting with
antibodies to phosphoserine 25 (PS25) or mannosidase I (Mann-1). (C) The GM130 phosphatase is insensitive to inhibitor-2. The
N73pepPS25 peptide (upper panel) or mitotic Golgi membranes (lower panel) were incubated in the absence of cytosol (no cytosol) or
with interphase cytosol in the absence (none) or presence of the inhibitors indicated (oka, okadaic acid; I-2, inhibitor-2; MC, microcys-
tin-LR) before analysis by blotting with antibodies to phosphoserine 25 (PS25), the NH2-terminal peptide (N73pep) or mannosidase I
(Mann-1). In some cases the cytosol was preincubated for 15 min in the absence (lane 3) or presence of increasing amounts of inhibitor-2
(lanes 5–7) before addition of the peptide or membranes. The activity of each inhibitor was confirmed by testing their ability to inhibit
the phosphatase activity of cytosol or purified PP1 and PP2A using phosphorylase a as control substrate (data not shown).The Journal of Cell Biology, Volume 149, 2000 352
activity towards phosphorylase a, and Western blotting
confirmed that the appropriate subunits were indeed ex-
pressed by the recombinant baculoviruses and that similar
levels of catalytic subunit were expressed in each combina-
torial infection (Fig. 8 B). The dramatic changes in GM130
dephosphorylation are therefore not due to differential
stabilization of the catalytic subunit, but rather reflect the
inherent ability of the Ba subunit to facilitate the recogni-
tion of GM130 by PP2A holoenzyme.
Localization of the Ba Regulatory Subunit of PP2A to 
Golgi Membranes
The Ba subunit of PP2A has been localized previously by
immunofluorescence microscopy to the cytoplasm, inter-
mediate filaments, and microtubules (Sontag et al., 1995;
Turowski et al., 1999). To determine whether the Ba sub-
unit is also localized to the Golgi complex, Golgi mem-
branes were purified from rat liver and analyzed by West-
ern blotting with antibodies to PP2A subunits. The Ba
subunit was present in the Golgi fraction at a similar con-
centration to that in total rat liver homogenate (Fig. 9 A).
The catalytic subunit was also present in the Golgi frac-
tion, although it was depleted compared with homogenate.
In contrast, no B9a subunit could be detected in the Golgi
fraction. Neither vimentin nor a-tubulin, which were
present in the homogenate, could be detected in the Golgi
fraction, suggesting that Ba is not present on contaminat-
Figure 7. Dephosphorylation of GM130 by purified phos-
phatases. The N73pepPS25 peptide (upper panel) or mitotic
Golgi membranes (lower panel) were incubated with increasing
amounts of purified PP1 or PP2A before immunoblotting with
antibodies to phosphoserine 25 (PS25), the NH2-terminal peptide
(N73pep) or mannosidase I (Mann-1). Equivalent amounts of
PP1 or PP2A were added in each case, as assayed using the con-
trol substrate phosphorylase a (data not shown). Relative phos-
phorylase phosphatase activities added were 1 (lanes 2 and 8), 2
(lanes 3 and 9), 4 (lanes 4 and 10), 8 (lanes 5 and 11), and 16
(lanes 6 and 12).
Figure 8. Isoform-specific dephos-
phorylation of GM130 by PP2A. (A)
Dephosphorylation of GM130 by
PP2A isoforms. Baculovirus recom-
binants were used to express PP2A
subunits in various combinations in
insect cells. Cells were harvested 64–
72 h after infection and lysates were
tested for their ability to dephos-
phorylate the N73pepPS25 peptide
(upper panel) or mitotic GM130 on
Golgi membranes (lower panel).
Amounts of each lysate added were
(from left to right): 1, 2, 4, 8, and 16
ml. Each lysate had a similar phos-
phatase activity assayed using phos-
phorylase a as the substrate. Rela-
tive phosphorylase a phosphatase
activities were 1, 1.6, 1.6, and 0.95 for none, AC, ACBa, and
ACB9a lysates, respectively. Noninfected Sf9 cells (none) had a
detectable level of GM130 phosphatase activity, which was not
increased by expression of the AC subunits alone or in combina-
tion with the B9a subunit. In contrast, the Ba subunit signifi-
cantly increased activity directed against phospho-GM130. (B)
Subunit expression analyzed by Western blotting. Equivalent
amounts of lysates from uninfected Sf9 cells (none) or cells in-
fected with recombinants expressing the AC, ACBa, or ACB9a
subunits of PP2A were subjected to SDS-PAGE and Western
blotting with antibodies specific for the catalytic subunit (C), the
A subunit, or the Ba or B9a regulatory subunits.Lowe et al. Mitotic Phosphorylation and Dephosphorylation of GM130 353
ing cytoskeletal elements. To address the possibility that
Ba might be on other membranes contaminating the Golgi
fraction, another round of purification using flotation on a
sucrose gradient was performed. The Golgi membranes
floated from the bottom of the gradient to the 0.4–1 M su-
crose interface (fraction 4), as determined by Western
blotting for mannosidase I (Fig. 9 B). All of the Ba present
in the starting material floated to the same position as the
Golgi membranes, and none was detected at the 1–1.2 M
and 1.2–1.6 M sucrose interfaces, where heavier mem-
branes such as the ER migrate (data not shown). The cata-
lytic subunit of PP2A also floated to the position of the
Golgi membranes (Fig. 9 B). Together, these finding sug-
gest Ba-containing PP2A is localized to the Golgi com-
plex, and that it is enriched there relative to other PP2A
isoforms.
Discussion
We previously used a biochemical approach to identify
GM130 as a mitotic phosphoprotein (Nakamura et al.,
1997; Lowe et al., 1998). We could show that GM130 is
phosphorylated on serine 25, and that phosphorylation in-
hibits binding to the vesicle-tethering factor p115 in vitro.
However, the temporal link between GM130 phosphory-
lation, p115 dissociation, and Golgi breakdown in vivo
was unclear. We therefore raised antibodies to phospho-
GM130 to study the timing of these events in cells. Phos-
phorylation of GM130 on serine 25, which occurs in mid-
prophase, coincides with the dissociation of p115 from
Golgi membranes, which is apparent already during pro-
phase and maximal by the time cells reach prometaphase.
Experiments in living cells have shown that the Golgi rib-
bon breaks down to large fragments (1–3 mm) arranged
around the nucleus early in prophase (Shima et al., 1998).
These fragments most likely correspond to discrete stacks
(Colman et al., 1985), which have been identified as early
mitotic breakdown intermediates by EM (Lucocq and
Warren, 1987; Misteli and Warren, 1995a). Quantitative
EM analysis has shown that the cross-sectional length of
the stacks decreases as cells progress through prophase.
This occurs before unstacking and is accompanied by the
accumulation of small 50–70-nm vesicles in the vicinity of
the stacks (Misteli and Warren, 1995a). By prometaphase,
no stacks remain, being replaced entirely by tubulo-vesicu-
lar clusters (Misteli and Warren, 1995a; Lucocq et al.,
1987). Phosphorylation of GM130 on serine 25 and disso-
ciation of p115 therefore occur at the same time as Golgi
cisternae are converted into small vesicles. This is consis-
tent with the proposal that GM130 phosphorylation is re-
sponsible for the inhibition of COPI vesicle tethering.
Biochemical studies strongly suggested that GM130 is
phosphorylated by Cdc2-cyclin B (Lowe et al., 1998).
Cdc2-cyclin B1 is thought to be activated during mid to
late prophase at about the time it is translocated from the
cytoplasm to the nucleus (Furuno et al., 1999; Hagting et
al., 1999). Translocation is a rapid event, preceding nu-
clear envelope breakdown by z10 min (Hagting et al.,
1999). This timing is consistent with the proposed role for
Cdc2 in phosphorylating nuclear lamins and triggering nu-
clear envelope breakdown (Peter et al., 1990). Our results,
which suggest that GM130 is phosphorylated around the
time cyclin B1 starts to translocate to the nucleus, are not
inconsistent with Cdc2-cyclin B1–mediated phosphoryla-
tion of GM130. However, it seems more likely that cyclin
B2 is the relevant kinase partner, since this cyclin has been
localized to the Golgi complex in interphase cells (Jack-
man et al., 1995). In prometaphase, cyclin B2 disperses
from the Golgi region and becomes cytoplasmic (Jackman
et al., 1995). Cdc2-cyclin B2 could therefore phosphorylate
GM130 (and perhaps other Golgi substrates) during pro-
phase to initiate Golgi complex disassembly before its dis-
sociation from the Golgi membranes.
Dephosphorylation of GM130 in telophase coincides
with the rebinding of p115 to mitotic Golgi fragments and
the congregation and coalescence of these fragments into
larger structures. EM analysis has shown that during this
time, mitotic Golgi clusters increase in size by accretion of
vesicles, and that these vesicles fuse with each other to
form cisternae that undergo stacking (Lucocq et al., 1989;
Souter et al., 1993). GM130 dephosphorylation therefore
coincides temporally with the accretion of Golgi vesicles
and their conversion into stacked cisternae, consistent
with the proposed role for p115 in the initial tethering of
Figure 9. Localization of the
Ba regulatory subunit of
PP2A to Golgi membranes.
(A) Equal amounts (10 mg)
of rat liver homogenate or
purified rat liver Golgi mem-
branes (purified 200-fold
over homogenate) were sub-
jected to SDS-PAGE and
Western blotting with anti-
bodies specific for the PP2A
catalytic subunit (C), PP2A
Ba  or B9a regulatory sub-
units, vimentin, or a-tubulin.
(B) Purified rat liver Golgi
membranes were further
fractionated by flotation on a
discontinuous sucrose gradient. Fractions were collected from the top, and proteins precipitated with methanol/chloroform before anal-
ysis by SDS-PAGE and Western blotting with antibodies specific for mannosidase I (Mann-1), or the catalytic (C) or Ba subunits of
PP2A. L, load. The positions of the 0.4–1 M sucrose (I), 1–1.2 M sucrose (II), and 1.2–1.6 M sucrose (III) interfaces are shown.The Journal of Cell Biology, Volume 149, 2000 354
Golgi vesicles during cisternal regrowth and in the initial
alignment of cisternae during stacking.
An alternative view of Golgi partitioning has recently
been put forward by Zaal and colleagues (1999). These au-
thors presented evidence suggesting that fragmentation of
the Golgi apparatus is followed, during metaphase, by fu-
sion of these fragments with the ER. This persists until late
telophase, when Golgi stacks are rebuilt at peripheral ER
exit sites. In this model, the partitioning of the Golgi appa-
ratus is not an autonomous function of this organelle but
rather a function of the ER that now contains it. The key
observation was the almost complete disappearance of
Golgi fragments during metaphase through early telo-
phase, using a variety of Golgi markers, including GM130.
This observation conflicted with our earlier fluorescence
data (Shima et al., 1997, 1998), which we have now con-
firmed by quantitating the distribution of GM130 during
mitosis. We find that GM130-containing Golgi fragments
are present throughout. Interestingly, we did observe a
drop in the amount of GM130 in these mitotic fragments
from metaphase through early telophase, the same period
observed by Zaal and colleagues (1999). But the drop was
never .50%, much less than the 98% reported by Zaal
and colleagues (1999) for b1,4-galactosyltransferase. One
could attribute this 50% drop to fusion of some mitotic
fragments with the ER. However, we prefer our original
interpretation, based on extensive stereological analysis,
that mitotic fragments shed vesicles into the surrounding
cytoplasm and these would be below the resolution of light
microscopy (Lucocq et al., 1989). This interpretation is
also in line with more recent data showing that mitotic
Golgi membranes can be separated from mitotic ER
(Jesch  and Linstedt, 1998) and that Golgi enzyme activity
cannot be detected in the ER during mitosis (Farmaki et
al., 1999). Further work is obviously needed to examine
the fate of those Golgi components that are no longer
found in fragments. However, it is important to note that
the presence of a substantial pool of Golgi fragments
throughout mitosis precludes the ER as the sole means of
partitioning the Golgi apparatus.
Golgi fragmentation induced by okadaic acid occurs
without GM130 phosphorylation on serine 25 or dissocia-
tion of p115 from Golgi membranes. Treatment of cells
with okadaic acid leads to an increase in the activity of
many protein kinases, resulting in a dramatic increase in
the overall cellular protein phosphorylation (Haystead et
al., 1989; Millward et al., 1999). However, in most cell
types there is little activation of Cdc2 (Ghosh et al., 1998).
Consistent with this, we found only slight effects upon his-
tone H1 kinase activity of NRK and HeLa cells (1.7-fold
increase in activity after okadaic acid treatment; data not
shown), in agreement with previous results (Lucocq et al.,
1991; Ajiro et al., 1996). Furthermore, in the majority of
okadaic acid–treated cells, we could not detect nuclear en-
velope breakdown or spindle formation (data not shown).
The lack of GM130 phosphorylation on serine 25 in oka-
daic acid–treated cells suggests that this residue is ex-
tremely specific for Cdc2. It also demonstrates that al-
though okadaic acid can mimic mitotic fragmentation
morphologically, the biochemical mechanisms involved
may be different. Clearly, kinases other than Cdc2 can
trigger Golgi fragmentation, and they may even do so in
mitosis, but to what extent okadaic acid activates the ki-
nases physiologically relevant for mitotic breakdown is un-
clear. Two kinases with demonstrated roles in regulation
of Golgi structure are MEK1 and PKD. MEK1 is acti-
vated in okadaic acid–treated cells (Gomez and Cohen,
1991), and could therefore be responsible for some of the
changes that occur during okadaic acid–induced Golgi
breakdown. Interestingly, it has been proposed that MEK1
mediates Golgi fragmentation in mitosis (Acharya et al.,
1998). PKD is activated by IQ and is responsible for bring-
ing about the fragmentation of the Golgi complex induced
by this drug (Jamora et al., 1999). Since both okadaic acid
and IQ did not induce phosphorylation of GM130, it is un-
likely that MEK1 and PKD have a role in the COPI mi-
totic Golgi fragmentation pathway. However it is possible
that they could play a role in the COPI-independent path-
way, and drugs such as okadaic acid and IQ might mimic
this pathway by activating these kinases. Further work is
necessary to determine if this is the case.
Several lines of evidence strongly suggest that PP2A is
the GM130 phosphatase. First, dephosphorylation of a
synthetic GM130 phosphopeptide (N73pepPS25) as well
as native mitotically phosphorylated GM130 was inhibited
by okadaic acid with an IC50 of z0.1 nM. PP2A is the only
known phosphatase that is sensitive to okadaic acid at
this concentration (Bialojan and Takai, 1988; Cohen,
1991). Second, dephosphorylation was insensitive to pro-
tein phosphatase inhibitor-2, a potent inhibitor of PP1 that
does not inhibit PP2A (Cohen, 1991). Third, purified
PP2A efficiently dephosphorylated both the phosphopep-
tide and native phospho-GM130, whereas PP1 at similar
levels had no effect. Fourth, recombinant baculovirus-
expressed PP2A dephosphorylated the phosphopeptide
and native phospho-GM130.
Dephosphorylation of GM130 by PP2A was dependent
upon the presence of the Ba regulatory subunit. This sub-
unit has been demonstrated to have an important role in
the dephosphorylation of several other cyclin-dependent
kinase substrates (Ferrigno et al., 1993; Mayer-Jaekel et
al., 1994). Cdc2-phosphorylated HMG-1Y (high mobility
group protein-1Y), histone H1, and caldesmon were effi-
ciently dephosphorylated by PP2A in vitro, but only when
the B subunit was present. Experiments using phospho-
peptide substrates have shown that the proline residue lo-
cated at the COOH-terminal side of Cdc2 phosphoryla-
tion sites is a negative determinant for dephosphorylation
by the PP2A catalytic subunit (Donella Deana et al.,
1990). The B subunit appears to overcome this inhibition,
making the Cdc2 site a preferred substrate for the holoen-
zyme (Ferrigno et al., 1993; Mayer-Jaekel et al., 1994).
Whereas other mitotic substrates of PP2A are bound to
exist, it is interesting to note that those described here are
all structural proteins involved in maintenance of chroma-
tin (HMG-1Y and histone H1), cytoskeleton (caldesmon),
and Golgi (GM130) architecture. The B subunit of PP2A
could therefore have an important role in reversing many
of the morphological changes brought about by activation
of Cdc2 in mitosis. Studies of PP2A function in vivo sup-
port a role for the B subunit in proper mitotic progression.
Strains of budding yeast that carry a mutation in the B
subunit gene lack a functional spindle assembly check-
point and are defective in cytokinesis (Minshull et al.,Lowe et al. Mitotic Phosphorylation and Dephosphorylation of GM130 355
1996; Wang and Burke, 1997), whereas mutations of the
corresponding gene in Drosophila cause abnormal sister
chromatid separation (Mayer-Jaekel et al., 1993). These
effects are likely a result of impaired dephosphorylation of
specific substrates by PP2A.
The Ba subunit of PP2A is present on purified rat liver
Golgi membranes, suggesting it may play a role in target-
ing of the catalytic subunit to the Golgi complex in vivo.
This would be consistent with previous work demonstrat-
ing a role for this subunit in determining PP2A subcellular
localization (Sontag et al., 1995; Turowski et al., 1999).
The reason why PP2A is active against GM130 only in telo-
phase and not earlier in mitosis is not clear. The Ba sub-
unit may dissociate from Golgi membranes during the
early stages of mitosis and reassociate during telophase, or
Ba-containing PP2A may become activated during telo-
phase. Previous work has failed to reveal dramatic changes
in overall PP2A localization or activity during the cell divi-
sion cycle (Ferrigno et al., 1993; Mayer-Jaekel et al., 1994),
but it cannot be excluded that subtle changes in distribu-
tion or levels of activity of particular PP2A isoforms could
modulate phosphatase activity towards distinct substrates.
In fact, it has been reported that the activity of microtu-
bule-associated PP2A is regulated in a cell cycle–depen-
dent manner (Sontag et al., 1995). Further work is clearly
necessary to elucidate the regulatory mechanisms that
control the correct timing of GM130 dephosphorylation.
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